Notably, elevated PSMD14 expression was markedly strongly linked to unfavorable poor prognoses in patients diagnosed with HNSC, LGG, LIHC, LUAD, mesothelioma (MESO), and PAAD, with the most pronounced association observed in PAAD (Figure 4B). The gene discussed is PSMD14; the disease is pancreatic adenocarcinoma.